Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment

• Main Authors: Yuri Murayama (Author), Hiromichi Hamada (Author), Yuki Shiko (Author), Yoshihiro Onouchi (Author), Nobuyuki Kakimoto (Author), Yoshihito Ozawa (Author), Hideki Hanaoka (Author), Akira Hata (Author), Hiroyuki Suzuki (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

BackgroundTo investigate risk factors for coronary arterial abnormalities (CAAs) and resistance to treatment in patients with Kawasaki disease (KD) receiving intravenous immunoglobulin (IVIG) plus ciclosporin A (CsA) as the first-line treatment, we performed a subanalysis of baseline data of partici...